Antonio C Fuentes-Fayos Selected Research

Somatostatin Receptors (Somatostatin Receptor)

1/2022

Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio C Fuentes-Fayos Research Topics

Disease

17	Neoplasms (Cancer) 02/2024 - 01/2019
6	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 10/2019
6	Pituitary Neoplasms (Pituitary Adenoma) 01/2022 - 01/2019
4	Glioblastoma (Glioblastoma Multiforme) 04/2023 - 12/2020
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2020 - 06/2019
3	Prolactinoma (Prolactinomas) 01/2020 - 01/2019
2	Obesity 12/2023 - 11/2021
2	Glioma (Gliomas) 01/2022 - 12/2020
1	Carcinoid Heart Disease 02/2024
1	Carcinoid Tumor (Carcinoid) 02/2024
1	Diarrhea 02/2024
1	Fibrosis (Cirrhosis) 02/2024
1	Heart Failure 02/2024
1	Inflammation (Inflammations) 12/2023
1	Hypoxia (Hypoxemia) 12/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022
1	Ovarian Neoplasms (Ovarian Cancer) 10/2021
1	Breast Neoplasms (Breast Cancer) 10/2021
1	Carcinogenesis 08/2021
1	Pituitary ACTH Hypersecretion 01/2021
1	Astrocytoma (Pilocytic Astrocytoma) 12/2020
1	Hyperlipidemias (Hyperlipidemia) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Acromegaly 06/2019

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2019
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2024 - 06/2019
5	RNA Splicing FactorsIBA 01/2023 - 01/2020
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2023 - 01/2020
4	Metformin (Glucophage)FDA LinkGeneric 04/2023 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2020
4	Hormones (Hormone)IBA 01/2020 - 01/2019
3	pladienolide BIBA 01/2022 - 01/2019
2	Simvastatin (Zocor)FDA LinkGeneric 04/2023 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 12/2020
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022 - 01/2021
2	GhrelinIBA 01/2022 - 11/2021
2	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2020
2	Phenformin (Fenformin)IBA 01/2021 - 01/2019
2	BuforminIBA 01/2021 - 01/2019
2	BiguanidesIBA 01/2021 - 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 02/2024
1	pro-brain natriuretic peptide (1-76)IBA 02/2024
1	telotristatIBA 02/2024
1	Octreotide (Sandostatin)FDA LinkGeneric 02/2024
1	NF-kappa B (NF-kB)IBA 12/2023
1	InflammasomesIBA 12/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Fibronectins (Fibronectin)IBA 01/2023
1	CateninsIBA 01/2022
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2022
1	pasireotideIBA 01/2022
1	ProlactinIBA 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	somatostatin receptor type 1IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 11/2021
1	ElementsIBA 11/2021
1	Insulin (Novolin)FDA Link 11/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2021
1	AMP-Activated Protein KinasesIBA 10/2021
1	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 08/2021
1	somatotropin releasing hormone receptorIBA 08/2021
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2021
1	MicroRNAs (MicroRNA)IBA 06/2020
1	Transcription Factors (Transcription Factor)IBA 06/2020
1	Growth Hormone (Somatotropin)IBA 06/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019

Therapy/Procedure

4	Therapeutics 04/2023 - 01/2021
1	Drug Therapy (Chemotherapy) 10/2021
1	Castration 01/2020